Treffer 1 - 1 von 1 für Suche 'Rao Srikanth, Ranganatha', Suchdauer: 0,28s
Treffer weiter einschränken
-
1
Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study von Mohan, M. V. T. Krishna, Prajapati, Arpitkumar, Kothari, Rushabh, Mandal, Srikrishna, Rao Srikanth, Ranganatha, Nagarkar, Rajnish, Khane, Shriram, Santa, Ayyagari, Dadke, Disha
Veröffentlicht in Clinical drug investigation
VolltextArtikel
Suchwerkzeuge:
Treffer weiter einschränken
Seite wird neu geladen, wenn Filter aktiviert oder ausgeschlossen wird.- Adolescent 1 Treffer 1
- Adult 1 Treffer 1
- Aged 1 Treffer 1
- Antineoplastic Agents, Immunological - Administration & Dosage 1 Treffer 1
- Antineoplastic Agents, Immunological - Adverse Effects 1 Treffer 1
- Antineoplastic Agents, Immunological - Therapeutic Use 1 Treffer 1
- Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage 1 Treffer 1
- Antineoplastic Combined Chemotherapy Protocols - Adverse Effects 1 Treffer 1
- Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use 1 Treffer 1
- Biological Products 1 Treffer 1
- Biosimilar Pharmaceuticals - Administration & Dosage 1 Treffer 1
- Biosimilar Pharmaceuticals - Adverse Effects 1 Treffer 1
- Biosimilar Pharmaceuticals - Pharmacology 1 Treffer 1
- Biosimilar Pharmaceuticals - Therapeutic Use 1 Treffer 1
- Breast Cancer 1 Treffer 1
- Breast Neoplasms - Drug Therapy 1 Treffer 1
- Breast Neoplasms - Pathology 1 Treffer 1
- Cancer Therapies 1 Treffer 1
- Docetaxel - Administration & Dosage 1 Treffer 1
- Docetaxel - Adverse Effects 1 Treffer 1
- Proquest Central (Alumni) 1 Treffer 1
- Proquest Central Uk/Ireland 1 Treffer 1
- Proquest Central 1 Treffer 1
- Springer Nature Oa Free Journals 1 Treffer 1
- Proquest One Community College 1 Treffer 1
- Medline 1 Treffer 1
- Infotrac Custom 1 Treffer 1
- Springerlink Journals 1 Treffer 1
- Journals@Ovid Complete 1 Treffer 1